🇺🇸 Ceftazidim in United States

115 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Sepsis — 18 reports (15.65%)
  2. Pneumonia — 16 reports (13.91%)
  3. Drug Ineffective — 14 reports (12.17%)
  4. Pancytopenia — 11 reports (9.57%)
  5. Bronchopulmonary Aspergillosis — 10 reports (8.7%)
  6. Neutropenia — 10 reports (8.7%)
  7. Thrombocytopenia — 10 reports (8.7%)
  8. Pyrexia — 9 reports (7.83%)
  9. Respiratory Failure — 9 reports (7.83%)
  10. Cytomegalovirus Infection — 8 reports (6.96%)

Source database →

Other Metabolic approved in United States

Frequently asked questions

Is Ceftazidim approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ceftazidim in United States?

Tel-Aviv Sourasky Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.